Anzeige
Meldung des Tages: Neue Bohrungen könnten die Story dieser Kupfer-Aktie komplett verändern

Immunic News

Aktie
WKN:  A2PHD4 ISIN:  US4525EP1011 US-Symbol:  IMUX Branche:  Biotechnologie Land:  USA
1,021 €
+0,071 €
+7,47%
23.03.26
Depot/Watchlist
Marktkapitalisierung *
47,04 Mio. €
Streubesitz
61,15%
KGV
-0,79
Index-Zuordnung
-

Immunic News

10.03.26 - EQS
EQS-News: Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
Issuer: Immunic AG / Key word(s): Patent Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium 10.03.2026 / 11:30 ...
10.03.26 - PR Newswire
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium
Immunic Announces Grant of Key European Patent Protecting Relevant Dosing Regimens for Vidofludimus Calcium PR Newswire
03.03.26 - EQS
EQS-News: Immunic to Participate in Investor Conferences in March
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Investor Conferences in March 03.03.2026 / 12:30 CET/CEST The issuer is solely responsible for the ...
03.03.26 - PR Newswire
Immunic to Participate in Investor Conferences in March
Immunic to Participate in Investor Conferences in March PR Newswire
26.02.26 - EQS
EQS-News: Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
Issuer: Immunic AG / Key word(s): Annual Results Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update 26.02.2026 / 12:30 CET/CEST The ...
26.02.26 - PR Newswire
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update
Immunic, Inc. Reports Year-End 2025 Financial Results and Provides Corporate Update PR Newswire
17.02.26 - EQS
EQS-News: Immunic Announces Closing of Oversubscribed Private Placement Financing
Issuer: Immunic AG / Key word(s): Financing Immunic Announces Closing of Oversubscribed Private Placement Financing 17.02.2026 / 22:05 CET/CEST The issuer is solely ...
17.02.26 - PR Newswire
Immunic Announces Closing of Oversubscribed Private Placement Financing
Immunic Announces Closing of Oversubscribed Private Placement Financing PR Newswire
13.02.26 - EQS
EQS-News: Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company
Issuer: Immunic AG / Key word(s): Financing Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-​Stage ...
13.02.26 - PR Newswire
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-​Stage Company PR Newswire
04.02.26 - EQS
EQS-News: Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Issuer: Immunic AG / Key word(s): Conference/Study results Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, ...
04.02.26 - PR Newswire
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis
Immunic to Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the ACTRIMS Forum 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis PR ...
07.01.26 - EQS
EQS-News: Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Issuer: Immunic AG / Key word(s): Miscellaneous/Conference Immunic Highlights 2025 Accomplishments and Upcoming Milestones 07.01.2026 / 12:30 CET/CEST The issuer is ...
07.01.26 - PR Newswire
Immunic Highlights 2025 Accomplishments and Upcoming Milestones
Immunic Highlights 2025 Accomplishments and Upcoming Milestones PR Newswire
26.11.25 - EQS
EQS-News: Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December 26.11.2025 / 12:30 CET/CEST The issuer ...
26.11.25 - PR Newswire
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December PR Newswire
13.11.25 - EQS
EQS-News: Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Issuer: Immunic AG / Key word(s): 9 Month figures Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update 13.11.2025 / 12:30 CET/CEST The ...
13.11.25 - PR Newswire
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update PR Newswire
29.10.25 - EQS
EQS-News: Immunic to Participate in Industry and Investor Conferences in November
Issuer: Immunic AG / Key word(s): Conference Immunic to Participate in Industry and Investor Conferences in November 29.10.2025 / 11:30 CET/CEST The issuer is solely ...
29.10.25 - PR Newswire
Immunic to Participate in Industry and Investor Conferences in November
Immunic to Participate in Industry and Investor Conferences in November PR Newswire

Newssuche

Videos

newspaper
23.03.26 -5,20%
Technical Trading: Gold Long nach Absturz
Gold Long Typ: Turbo Open End WKN: VC5S7W Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »